Why is the New York Times Writing so Much about Alzheimer's Disease Therapies?

Por Tamas Bartfai
Publicado em 2010-01-01

Why is the New York Times Writing so Much about Alzheimer's Disease Therapies?

Por Bartfai, Tamas
Publicado no ScientificWorldJournal (2010)

Long-term atropine treatment lowers the efficacy of carbachol to stimulate phosphatidylinositol breakdown in the cerebral cortex and hippocampus of rats.

Por Goobar, L, Bartfai, T
Publicado em 1988

No association of maternal vitamin E intake with higher risk of cardiovascular malformations in children: a population-based case–control study

Por Szilasi, Mária, Bártfai, Liza, Bártfai, Zoltán, Bánhidy, Ferenc, Czeizel, Andrew E.
Publicado em 2011

Analyzing the validity of GalR1 and GalR2 antibodies using knockout mice

Por Lu, Xiaoying, Bartfai, Tamas
Publicado em 2009

Fever

Por Bartfai, Tamas, Conti, Bruno
Publicado em 2010

Single Cell Transcriptomics of Hypothalamic Warm Sensitive Neurons that Control Core Body Temperature and Fever Response

Por Eberwine, James, Bartfai, Tamas
Publicado em 2010

Molecules affecting hypothalamic control of core body temperature in response to calorie intake

Por Bartfai, Tamas, Conti, Bruno
Publicado em 2012

Alzheimer Drug Trials: Combination of Safe and Efficacious Biologicals to Break the Amyloidosis-Neuroinflammation Vicious Cycle

Por Tamas Bartfai, Graham V. Lees
Publicado em 2020-04-01

The effects of atropine on [(3)H]acetylcholine secretion from guinea-pig myenteric plexus evoked electrically or by high potassium

Por Alberts, P., Bartfai, T., Stjärne, L.
Publicado em 1982

Site(s) and ionic basis of α-autoinhibition and facilitation of [(3)H]noradrenaline secretion in guinea-pig vas deferens

Por Alberts, P., Bartfai, T., Stjärne, L.
Publicado em 1981

It all happens between Toll receptors and Caspase 1

Por Sanchez-Alavez, Manuel, Bartfai, Tamas
Publicado em 2007

Positive allosteric modulators to peptide GPCRs: a promising class of drugs

Por Bartfai, Tamas, Wang, Ming-wei
Publicado em 2013

Pharma TARP: A Troubled Asset Relief Program for Novel, Abandoned Projects in the Pharmaceutical Industry

Por Bartfai, Tamas, Lees, Graham Vaughan
Publicado no ScientificWorldJournal (2011)

MODERN DIAGNOSTIC EQUIPMENTS IN ENERGETIC MEASUREMENT

Por Zoltán Bártfai, Zoltán Blahunka, Rajmund Lefánti
Publicado em 2012-05-01

Regulation of synthesis of guanosine 3':5'-cyclic monophosphate in neuroblastoma cells.

Por Bartfai, T, Breakefield, X O, Greengard, P
Publicado em 1978

Bidirectional regulation of stress responses by galanin in mice: Involvement of galanin receptor subtype 1

Por Mitsukawa, Kayo, Lu, Xiaoying, Bartfai, Tamas
Publicado em 2009

Drug targets: single-cell transcriptomics hastens unbiased discovery

Por Bartfai, Tamas, Buckley, Peter T., Eberwine, James
Publicado em 2011

Predicting Outcome for Early Attention Training After Acquired Brain Injury

Por Aniko Bartfai, Aniko Bartfai, Mattias Elg, Marie-Louise Schult, Marie-Louise Schult, Gabriela Markovic, Gabriela Markovic
Publicado em 2022-05-01

A steady-state kinetic model of butyrylcholinesterase from horse plasma

Por Augustinsson, Klas-Bertil, Bartfai, Tamas, Mannervik, Bengt
Publicado em 1974